Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 908-300-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
- On rat Sprague-Dawley rats male and female (n = 6 rats/group), LD50 for oral administration of ScFOS in this study was > 9000 mg/kg bw.
- On JcL-IcR mice (n = 6 mice/group), LD50 for oral administration of ScFOS in this study was > 9000 mg/kg bw.
Oral route:
A study performed according to a method similar to OECD 420 guideline was carried out with ScFOS (Manish et al 2018). In this study, the test item was administered as a single oral dose at the dose levels of 2000, 5000, and 9000 mg/kg to rat male /and female (n= 5 rats/sex/group). As a results, no clinical signs, no mortality, no gross pathological abnormalities, no effects on body weight and feed consumption at any dose level were observed. The LD50 was > 9000 mg/kg bw (Highest dose tested).
Two others studies were performed by oral route on rat and mice (Takeda et al 1982).
Dermal route:
A study performed according to a method similar to OECD 402 guideline was carried out with ScFOs (CRL 2021). In this study, ScFOs was administered to a single female Wistar Han rat by a single dermal application at 2000 mg/kg body weight for 24 hours in a range finder study.Based on the results, the main study was performed by dosing two additional females at 2000 mg/kg. As a results, no mortality, no signs of systemic toxicity, no abnormalities at macroscopic postmortem, were observed at any dose level. The body weight gain shown by the animals during the observation period was within the range expected for rats used in this type of study. The LD50 determined in the GLP guideline dermal toxicity study performed on female rats was greater than 2000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2018
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study without detailed documentation
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- not specified
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
- Limit test:
- no
- Specific details on test material used for the study:
- FOS (FOSSENCE TM) used for the experiments was provided by Tata Chemicals Limited (Tamilnadu, India) and stored at ambient conditions (>15°C to <25°C).
- CAS no. 308066-66-2
- Composition (on dry basis)
- FOS: 95.46%
a) 1-Kestose (GF2): 40.23%
b) Nystose (GF3):47.15%
c) 1F-Fructofuranosylnystose (GF4): 8.08%
- Other sugars 4.50%
a) Glycerol: 1.40%
b) Fructose: 0.36%
c) Arabitol: 0.36%
d) Glucose: 0.63%
e) Sucrose: 1.75%
- Physical appearance Fine white powder
- Moisture content (as per CoA): 2.26% - Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- The test item was mixed in Milli-Q water and administered as a single oral dose at the dose levels of 2000, 5000, and 9000 mg/kg
5 Wistar rats of each sex were randomly assigned to 4 groups (control, 2000, 5000, and 9000 mg/kg). - Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- Milli-Q water.
- Details on oral exposure:
- The highest dose of 9000 mg/kg was considered as maximum feasible dose from oral administration perspective considering high viscosity factor and dose volume.
The dose volume employed was 15 mL/kg body weight. - Doses:
- 2000, 5000, and 9000 mg/kg
- No. of animals per sex per dose:
- n= 5 rats/sex/group
- Control animals:
- yes
- Remarks:
- Milli-Q water was administered to control group rats.
- Details on study design:
- The rats were observed for clinical signs or mortality, and body weights and feed consumption were measured. All the rats were euthanized under isoflurane anesthesia on day 15, and gross pathological examinations were performed.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 9 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- Oral gavage administration of test item i did not reveal any mortality at 2000, 5000, and 9000 mg/kg body weight.
- Clinical signs:
- other: other: other: Oral gavage administration of test item i did not reveal any clinical signs at 2000, 5000, and 9000 mg/kg body weight.
- Gross pathology:
- Necropsy at the end of study (day 15 post-dose) did not reveal any gross pathological abnormalities.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the test conditions, Wistar rats did not reveal any clinical signs, mortality, on body weight, and feed consumption at any dose level. No gross pathological abnormalities were also observed after necropsy. The MTD and the LD50 were > 9000 mg/kg bw (Highest dose tested).
- Executive summary:
The objective of this study was to evaluate the toxicity of FOS product FOSSENCETM following a single oral administration in rats according to methods similar to OECD 420 guidelines. The study was GLP compliant.
The FOSSENCETM was mixed in Milli-Q water and administered as a single oral dose at the dose levels of 2000, 5000, and 9000 mg/kg (n=5 rats/sex/group). The highest dose of 9000 mg/kg was considered as maximum feasible dose from oral administration perspective considering high viscosity factor and dose volume.
Under the test conditions, Wistar rats did not reveal any clinical signs, mortality, on body weight, and feed consumption at any dose level. No gross pathological abnormalities were also observed after necropsy. The MTD (Maximum Tolerable Dose) and the LD50 were > 9000 mg/kg bw (Highest dose tested).
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 9 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 05 July 2021 - 04 Augustus 2021
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity: Fixed Dose Procedure)
- Version / remarks:
- 2017
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
- Limit test:
- yes
- Specific details on test material used for the study:
- Identification: Actilight 950P Premium "Fructo-Oligosaccharides"
Substance: Short-chain fructo-oligosaccharides
EC No.: 908-300-1
Appearance: White powder
Purity: 95.4%
COMPOSITION:
scFOS is short chains of fructose molecules linked to a molecule of sucrose (glucose-fructose disaccharide). Thus, scFOS is a multiconstituent substance composed of three oligosaccharides: 1-kestose (GF2), nystose (GF3) and fructosyl-nystose (GF4).
With:
- TOTAL FOS: 95.4 expressed as dry matter
- Kestose (GF2): 39.2% FOS
- Nystose (GF3): 47.6% FOS
- 1F-Fructofuranosylnystose (GF4:) 13.6% FOS
- Glucose +Fructose + Saccharose : 4.6% expressed as dry matter - Species:
- rat
- Strain:
- Wistar
- Remarks:
- (HAN)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS:
- 3 females (nulliparous and non-pregnant)
- Age at dosing initiation: Young adult animals (approximately 11-12 weeks old)
- Weight at dosing initiation: 168 - 178 g
- Housing: On arrival, animals were group housed (up to 5 animals of the same sex together) in polycarbonate cages (Makrolon MIV type; height 18 cm.). During the study animals were individually housed in polycarbonate cages (Makrolon MIII type; height 18 cm.) containing sterilized wooden fibers as bedding material equipped with water bottles. For psychological/environmental enrichment, animals were provided with paper.
- Diet: Pelleted rodent diet (SM R/M-Z from SSNIFF® Spezialdiäten GmbH, Soest, Germany), ad libitum.
- Water: municipal tap water, ad libitum.
- Acclimation period: at least 5 days
CONTAMINANT ANALYSIS
Periodic analysis of the water was performed and feed was analyzed by the supplier for nutritional components and environmental contaminants. It is considered that there were no known contaminants in the feed or water that would interfere with the objectives of the study.
ENVIRONMENTAL CONDITIONS
Temperature (°C): 21 - 22
Humidity (%): 54 - 78
Air changes (per hr): >= 10 (no air recirculation)
Photoperiod (hrs dark/hrs light): 12/12
IN-LIFE DATES: From: 06 July 2021 To: 04 Augustus 2021 - Type of coverage:
- semiocclusive
- Vehicle:
- water
- Remarks:
- (Elix)
- Details on dermal exposure:
- TEST MATERIAL
The test substance was ground to a powder using a mortar and pestle prior to weighing. The weighed samples of the test substance were kept at room temperature and dosed within 4 hours after removal from the storage container. Based on the test item data provided by the Sponsor, it was considered that the test item remained stable during this relatively short time period. The samples were applied after moistening with 0.3 mL water (Elix), to ensure close contact to the skin.
TEST SITE
Area of exposure: 18 cm^2
% coverage: approx. 10% of the total body surface
Type of wrap if used: a surgical gauze patch (Surgy 1D), successively covered with Coban elastic bandage. A piece of Micropore tape was additionally used for fixation of the bandages.
REMOVAL OF TEST SUBSTANCE
- Washing: water
- Time after start of exposure: 24 hours - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bodyweight
- No. of animals per sex per dose:
- 3 females
- Control animals:
- not required
- Details on study design:
- RANGEFINDING STUDY
A range finding study was performed in order to select the dose causing no mortality or significant toxicity to be used in the main study. One animal was dosed at 2000 mg/kg bw.
MAIN STUDY
- Duration of observation period following administration: 14 days
- Frequency of observations: on the day of dosing (at least three times) and once daily thereafter
- Mortality: twice daily
- Body weights: on day 1 (pre-dose), 8 and 15
- Irritation: The skin reactions were assessed approximately 24, 48 and 72 hours after the removal of the dressing and test item and thereafter once daily. Adjacent areas of untreated skin of each animal served as controls.
- Necropsy of survivors performed: yes - Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality occurred.
- Clinical signs:
- other: No signs of systemic toxicity were observed.
- Gross pathology:
- No abnormalities were found at macroscopic post mortem examination of the animals.
- Other findings:
- No irritation was noted for any of the animals at any time point
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based on the results of an acute dermal study, performed according to OECD guideline 402 and in accordance with GLP principles, the dermal LD50 value of the test substance in female Wistar Han rats was determined to exceed 2000 mg/kg bodyweight. As a consequence, the test substance is not classified according to CLP criteria.
- Executive summary:
The objective of this study was to determine the potential toxicity of ScFOS, when given by a single dermal dose.
The study was carried out according to the guidelines OECD No. 402 (2017) "Acute Dermal Toxicity".
Initially, ScFOS was administered to a single female Wistar Han rat by a single dermal application at 2000 mg/kg body weight for 24 hours in a range finder study.
Based on the results, the main study was performed by dosing two additional females at 2000 mg/kg. All animals were subjected to daily observations and weekly determination of body
weight. Macroscopic examination was performed after terminal sacrifice (Day 15).
No mortality occurred.
No signs of systemic toxicity were noted in any of the animals. Furthermore, no irritation was noted for any of the animals at any time point.
The body weight gain shown by the animals during the observation period was within the range expected for rats used in this type of study.
No abnormalities were found at macroscopic postmortem examination of the animals.
The dermal LD50 value of Fructo-oligosaccharides in Wistar Han rats was established to exceed 2000 mg/kg body weight.
Based on these results, ScFOS does not have to be classified and has no obligatory labelling requirement for acute dermal toxicity according to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) of the United Nations (2017) (including all amendments) and Regulation (EC) No 1272/2008 on classification, labelling and packaging of items and mixtures (including all amendments).
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- > 2 000 mg/kg bw
Additional information
Acute oral toxicity: an experimental study performed under GLP compliance and in accordance with a method similar to a OECD TG 420 was flagged as a key study and assigned a Klimisch score of 2.
Acute dermal toxicity: an experimental study performed under GLP compliance and in accordance with OECD TG 402 was flagged as a key study and assigned a Klimisch score of 1.
Justification for classification or non-classification
Acute oral toxicity: Based on the available data, ScFOS is not classified for acute oral toxicity according to the CLP Regulation 1272/2008 as the LD50 is higher than 9000 mg/kg bw.
Acute dermal toxicity: Based on the available data, ScFOS is not classified for acute dermal toxicity according to the CLP Regulation 1272/2008 as the LD50 is higher than 2000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.